For a PDF version of the article click here
Medical News, March 2011
Written by Lisa English Hinkle
For a physician, treating a patient in a nursing home can be very different from treating a patient in a hospital. Because long-term care facilities typically do not have their own pharmacy, are not eligible to become DEA registrants, and do not employ full-time physicians, providing medications in a timely manner to residents is not always easy. Even though state and federal regulations require quality and timeliness of medical and pharmaceutical care, obtaining the necessary authorization to satisfy DEA requirements for prescribing and dispensing drugs to nursing facility residents can cause lengthy delays. As a result of these delays, 93 percent of medical directors surveyed by the American Medical Directors Association ("AMDA") reported patients suffering uncontrolled pain due to the delays, 50 percent reported these delays as a daily occurrence, and 25 percent reported that their facility had to send patients to the hospital to obtain controlled substance medications because they could not obtain the necessary pain medication at the long-term care facility in a timely manner. 1 With this in mind, it is important that physicians know what is required to avoid these delays for their patients in nursing homes.
Traditionally, prescribing in the long-term-care setting involved a three-way communication — a nurse assessed a change in a resident's condition, the nurse contacted the physician to describe the resident's symptoms, the physician made a treatment decision that the nurse recorded in the resident's clinical record, and the nurse implemented the orders by contacting the pharmacist on the physician's behalf. Even though the physician remained responsible for patient care, the nursing facility nurse acted as the agent of the prescribing physician. In 2011, despite prior statements to the contrary, the DEA released a public statement announcing that its interpretation of the Controlled Substances Act did not recognize an agency relationship between a prescribing physician and long-term-care nurse. 2 Year later, in 2009, the DEA initiated vigorous enforcement actions assessing large fines against several long-term-care pharmacies in Ohio and North Carolina based on this 2001 interpretation. DEA audits have also been conducted in long-term care pharmacies in Virginia and Wisconsin. Though the DEA stated that pharmacies, not long-term care facilities, have been its target, the American Health Care Association reports that the DEA's enforcement actions have impacted long-term care resident's access to pain medications.
In response to the DEA's aggressive enforcement action, the American Medical Association, AMDA, American Academy of Family Physicians, American Academy of Hospice and Palliative Medicine, and the American Geriatrics Society have worked together to lobby congress and the DEA to allow nursing facility nurses to act as agents of prescribing physicians. This coalition has also developed a "Tip Sheet" to help physicians, nursing homes and pharmacists comply with existing law. The coalition recommends that physicians always carry a prescription to the pharmacy and purchase a home fax machine for after-hour and weekend calls. 3 The DEA also counsels that so long as the pharmacist contacts the physician after speaking with the nursing facility nurse, all requirements will be satisfied.
While the DEA allows physicians to call in prescriptions for Schedule III-V controlled substances to the pharmacy, Schedule II drugs may only be dispensed pursuant to an original, written prescription signed by a physician. In the nursing facility setting, a physician or his agent may fax (as opposed to hand-deliver) a prescription written and signed by the physician for the resident to a pharmacy. This exception for nursing facilities allows a nurse to call the physician to relay information about the resident's condition, and then the physician can fax a prescription directly to the pharmacy from his or her remote location. Under these circumstances, the fax serves as the original prescription. 4 Kentucky, however, requires that the faxed Schedule II prescription be followed by an original written prescription to the pharmacy within seven calendar days. 5
In emergency situations, the DEA allows physicians to call in prescriptions to the pharmacy when followed by a written prescription within seven days. Under the pharmacy's DEA registration, a nursing facility may keep a secured "emergency kit" stocked with commonly dispensed controlled substances on-site. The DEA allows drugs from the kit to be dispensed by authorized nursing facility personnel when a physician is off-site so long as a physician first calls in or faxes an emergency prescription to the pharmacy. 6 These exceptions to the general rule requiring written prescriptions permit residents to receive immediate pharmaceutical treatment.
The DEA has announced that its new regulations allowing e-prescribing will make physician prescribing of controlled substances to long-term care residents more effective. On June 1, 2010, the DEA's Interim Final Rule 7 became final and established a voluntary application process for practitioners to obtain the authority to issue electronic prescriptions. The rule allows credentialed practitioners to use a computer, laptop or PDA device to send a prescription to a pharmacy from a remote location instantaneously. The DEA's new process is extremely complicated and requires an applicant provider (pharmacy or other institution) to present evidence that its system is compliant with the DEA's requirements and requires physician prescribers to obtain complex authentication credentials. Since nursing facilities are not DEA-registered institutions and the DEA-registered physician is often off-site, several pharmacist associations have requested that the DEA clarify how e-prescribing will be implemented in the nursing facility setting. Whether e-prescribing will enhance a physician's ability to treat nursing facility patients is yet to be determined.
Providing timely care is important if nursing facility patients are to receive high-quality and compassionate medical care. Physicians must be aware of the DEA's special requirements for prescribing controlled substances to nursing home residents and adapt their practices so unnecessary delays in delivering medical treatment can be avoided.
1 American Medical Association. Letter from AMA Executive Vice President, CEO to Mark W. Caverly, Chief Liaison and Policy Section, Office of Diversion Control, DEA. August 30, 2010.
2 66 Fed. Reg. 20834, April 25, 2001.
3 AAFP, AAHPM, AGS, AMA, AMDA- Dedicated to Long Term Care. "Prescribing controlled substances in long-term care: Tips for practicing clinicians on the go." August 2010.
4 21 U.S.C. § 829 (a); United States Senate Special Committee on Aging, March 24, 2010, Debut Assistant Administrator, Joseph Rannazzisi presented, "The War on Drugs Meets the War on Pain: Nursing Home Patients Caught in the Crossfire."
5 902 KAR 55:080 and 55:095 Section 2.
6 902 KAR 55:070.
7 Federal Register/Vol. 75, No. 61, p. 16, 236, March 31, 2010.
Lisa English Hinkle is a Member of McBrayer law. Ms. Hinkle concentrates her practice area in healthcare law and is located in the firm's Lexington office. She can be reached at email@example.com or at 859-231-8780, ext. 1256.
This article is intended as a summary of newly enacted federal law and does not constitute legal advice.